Everest Medicines Limited (HKG:1952)

Accolade Revenue

In the year 2024, Everest Medicines had annual revenue of 706.68M CNY with 461.16% growth. Everest Medicines had revenue of 405.16M in the half year ending December 31, 2024, with 3,348.77% growth.

• Revenue: 706.68M CNY
• Revenue Growth: +461.16%
• P/S Ratio: 32.64
• Revenue / Employee: 1.06M CNY
• Employees: 665
• Market Cap: 24.55B USD

Revenue Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	706.68M	580.75M	461.16%
Dec 31, 2023	125.93M	113.14M	884.46%
Dec 31, 2022	12.79M	12.74M	23,588.89%
Dec 31, 2021	54.00K	-	-
Dec 31, 2020	-	-	-